Smith & Nephew.
a company producing medical equipment
- Reports this week
- 0
- Active events
- 0
- Connections
- 29
What's happening
Earlier this month
One to three months ago
-
Morgan Stanley downgraded Smith & Nephew's stock rating from overweight to equal weight on September 3, 2026.Some support2 reports
-
A report argues that Non-Executive Directors (NEDs) require additional time.Some support1 report
-
John Rogers has been appointed as the Chief Financial Officer of Smith & Nephew.Some support2 reports
Gone quiet
No new reports in 90+ days-
Jon Osborne was promoted to Chief Commercial Officer at Smith & Nephew.Some support1 report
-
Royal Bank of Canada received Form 13F filings from investors regarding increased holdings in Smith & Nephew shares.Some support1 report
-
Orthofix, Stryker, and Smith & Nephew are competing in the pediatric intramedullary nails market.Some support1 report1 development inside
-
Smith & Nephew has better valuation metrics and earnings outlook.Speculative1 report
-
Amgen and Smith & Nephew are key players in the US calciphylaxis market.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Smith & Nephew this week
News at the entities that move Smith & Nephew most-
Securities and Exchange Commission StructuralA company held a meeting and furnished a proxy statement to the Securities and Exchange Commission on November 1, 2026.Moves Smith & Nephew
-
Royal Bank of Canada TransactionalRoyal Bank of Canada and Deutsche Bank issued rating updates for GE Aerospace, with MarketBeat providing consensus data.Moves Smith & Nephew
-
Bank of America OperationalBank of America, Deutsche Bank, and Truist Financial reduced their price targets for Costco on November 11, 2026.Moves Smith & Nephew
-
Morgan Stanley TransactionalAnalyst rating updates for IONQ as of June 19, 2026, with Jefferies setting a $85 price target and Morgan Stanley lowering theirs to $48.50.Moves Smith & Nephew
Connections
The 8 strongest of 29, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
John Rogers Structural
John Rogers serves as the Chief Financial Officer for Smith & Nephew.
-
Securities and Exchange Commission Structural
Smith & Nephew operates under the mandatory disclosure and oversight jurisdiction of the U.S. Securities and Exchange Commission.
-
Royal Bank of Canada Transactional
Royal Bank of Canada increased its stake in Smith & Nephew shares.
-
Morgan Stanley Transactional
Morgan Stanley downgraded Smith & Nephew's stock rating from overweight to equal weight.
-
Bank of America Operational
Bank of America analysts influenced Smith & Nephew by downgrading its rating based on research notes.
-
HealthShare Transactional
HealthShare initiated a tender process for implants, involving Smith & Nephew.
-
Jon Osborne Transactional
Jon Osborne previously worked at Smith & Nephew.
-
Willis Towers Watson Mentioned together
The relationship is mentioned in a single, uninformative snapshot regarding corporate governance.
History
Events by the month they beganNovember 2026
1 eventSeptember 2026
1 eventAugust 2026
4 events- A report argues that Non-Executive Directors (NEDs) require additional time.
- John Rogers has been appointed as the Chief Financial Officer of Smith & Nephew.
- Jon Osborne was promoted to Chief Commercial Officer at Smith & Nephew.
- Royal Bank of Canada received Form 13F filings from investors regarding increased holdings in Smith & Nephew shares.